Back to Search Start Over

Experimental Model of Human Malignant Mesothelioma in Athymic Mice

Authors :
David Cottet-Dumoulin
Anna Faivre
Didier J. Colin
Stéphane Germain
Véronique Serre-Beinier
Frédéric Triponez
Source :
International Journal of Molecular Sciences, Volume 19, Issue 7, International Journal of Molecular Sciences, Vol. 19, No 7 (2018) P. 1881, International Journal of Molecular Sciences, Vol 19, Iss 7, p 1881 (2018)
Publication Year :
2018
Publisher :
Multidisciplinary Digital Publishing Institute, 2018.

Abstract

Malignant pleural mesothelioma (MPM) is a thoracic aggressive cancer caused by asbestos exposure, which is difficult to diagnose and treat. Here, we characterized an in vivo orthotopic xenograft model consisting of human mesothelioma cells (designed as H2052/484) derived from a pleural NCI-H2052 tumor injected in partially immunodeficient athymic mice. We assessed tumor formation and tumor-dependent patterns of inflammation. H2052/484 cells conserved their mesothelioma phenotype and most characteristics from the parental NCI-H2052 cells. After intra-thoracic injection of H2052/484 cells, thoracic tumors developed in nearly all mice (86%) within 14 days, faster than from parental NCI-H2052 cells. When the mice were euthanized, the pleural lavage fluid was examined for immune cell profiles. The pleural immune cell population increased with tumor development. Interestingly, the proportion of myeloid-derived suppressor cell and macrophage (especially CD206+ M2 macrophages) populations increased in the pleural fluid of mice with large mesothelioma development, as previously observed in immunocompetent mice. This reliable orthotopic model recapitulates human mesothelioma and may be used for the study of new treatment strategies.

Details

Language :
English
ISSN :
14220067 and 16616596
Database :
OpenAIRE
Journal :
International Journal of Molecular Sciences
Accession number :
edsair.doi.dedup.....16435ed0a8c7f085661e70091d692656
Full Text :
https://doi.org/10.3390/ijms19071881